Health Condition 1: J452- Mild intermittent asthma
Conditions
Interventions
Intervention1: Laooq-e-Zeequn Nafas: 5gm twice daily to be taken with lukewarm water for four weeks
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Males and females of 18-65 years. 2.Patients of Bronchial Asthma for at least 6 months presenting with at least one of the following symptoms: a.Wheeze b.Shortness of breath c.Chest tightness and cough that vary over time and in intensity, d.Expiratory airflow limitation as suggested by a decreased FEV1 3.Objective evidence for reversible airway obstruction (>=12% and >=200 mL change in FEV1 and/or a 25% and 60 L/min change in PEFR) either spontaneously or after treatment. 4.Patients with Asthma Control Questionnaire Score > 1.5.
Exclusion criteria
Exclusion criteria: 1.FEV1/FVC ratio 2.Pregnant and lactating mother 3.Patient with other Respiratory Tract Infections, tuberculosis and malignancy. 4.Patient of Presence of chronic cough with expectoration for 2-3 months in each of 2 successive years. 5.Patient with co-morbidities, Diabetes Mellitus, Hepatic and Renal Insufficiency. 6.Patients with Tobacco Smoking. 7.Patient with regular use of oral or systemic corticosteroids for conditions other than Asthma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of Zeequn Nafas (Bronchial Asthma)Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed